Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study, Evaluating the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution in Subjects With Social Anxiety Disorder

NCT05600114 is registered in ClinicalTrials.gov with EmpowerPharm Inc. as lead sponsor.

NCT NCT05600114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05600114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study, Evaluating the Efficacy, Safety, and Tolerability of Cannabidiol Oral Solution in Subjects With Social Anxiety Disorder
Lead sponsor
EmpowerPharm Inc.
Phase
Phase 2
Overall status
Completed
Start date
October 27, 2022
Completion date
December 13, 2023
Enrollment
239 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

social anxiety disorder